Florida Cancer Specialists & Research Institute, LLC, physicians and senior leaders are co-authors of a study that confirms the effectiveness of trilaciclib for the treatment of adult patients with extensive-stage small cell lung cancer.
Lucio Gordan, MD, President & Managing Physician of Florida Cancer Specialists & Research Institute, LLC, talked with Kevin Keegan, General Manager of Oncology Business with Illumina, about how FCS is bringing precision oncology through analysis of real-world data, innovative technology and research to cancer patients being treated in community settings.
Florida Cancer Specialists & Research Institute announced a partnership with IDEOology Health to serve as the exclusive provider of multi-channel medical education for the providers within the statewide practice.
How the Shortage of a $15 Cancer Drug Is Upending Treatment mysanantonio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mysanantonio.com Daily Mail and Mail on Sunday newspapers.